NHS Federated Data Platform

Seamus Logan Excerpts

Thursday 16th April 2026 Westminster Hall

[Seamus Logan (Aberdeenshire North and Moray East) (SNP)]

It is a pleasure to serve under you, Dame Siobhain. I thank the hon. Member for Newton Abbot (Martin Wrigley) for securing this important debate and for his excellent speech, demonstrating tremendous technical expertise.

This £330 million deal signed in 2023 with controversial American spy tech firm Palantir to use its tech on the federated data platform may turn out to be another gigantic waste of taxpayers’ hard-earned money. This is not just about money; it is also a moral and ethical misstep, given this firm’s links to work with the Israeli military and with the disgraced US Immigration and Customs Enforcement agency—so-called ICE. Members and the general public will be aware that health data provided for one purpose has been used to track, detain and deport so-called illegal immigrants in America.

There are now persistent reports that issues of trust in the NHS among the wider public over this firm’s clear breach of data protection may lead the Government to use a break clause in the contract in 2027 to prevent renewal of this seven-year deal. I know that the BMA is not on the Secretary of State’s Christmas card list, or possibly the Minister’s, but he would do well to note the briefing it issued only yesterday, in which it calls for the use of the break clause and the retendering of this contract. If the Government are serious about tech sovereignty and investing in UK tech and AI, that is what they must do.

The roll-out of Scotland’s MyCare.scot app begins this month, with the Scottish Cabinet Secretary for Health and Social Care describing it as the “most comprehensive” NHS app in the UK, created in-house and free from dodgy tech giants. I see the Minister laughing, but I want to reinforce that point, because it was made today by the First Minister of Scotland, John Swinney, at the launch of our manifesto.

To be fair, Palantir says that it will not use health data outwith the NHS as it would constitute a breach of contract and would, of course, be illegal, but England faces the rise of a political party that could change the law to suit its political purposes and ride roughshod over our basic privacy and human rights protections. If Members do not believe me, they should look at the US of A.

In conclusion, I hope the Minister will clarify in his response whether the situation is under review, and I urge the Government to reconsider their position, to implement the break clause next year and to invest in our own solutions, just as Scotland is doing.

--- Later in debate ---

[Dr Ahmed]

I am going to carry on for a bit longer.

The hon. Member for Aberdeenshire North and Moray East (Seamus Logan) tempts me with his speech, and he knows that I cannot resist his temptation. He spoke about Scotland and he will know that I am an NHS surgeon in Scotland. I hope he thinks that I can speak with some authority about the NHS in Scotland, so let me tell him a few things about the digital architecture in the NHS there.

The NHS app has been running successfully in England for over eight years. Three out of four people in the NHS in England have that app. To clarify, the app is not Palantir; it has been devised organically on the ground by NHS England—by clinicians and by technologists. It now serves millions of patients to book test results, screenings and appointments—including GP appointments —to end the 8 am rush.

The hon. Member for Aberdeenshire North and Moray East spoke about the MyCare app in Scotland. That remains a far-fetched dream rather than a reality. The limit of the ambition of that app seems to be, as I understand it, a dermatology service in one part of Scotland called Lanarkshire, for those who are not familiar with Scotland. It is a million miles away from what has been developed down here in England.

[Seamus Logan]

Will the Minister give way?

[Dr Ahmed]

I will not; I am going to carry on—and I will tell the hon. Gentleman something further. The NHS in England was quite happy to use the expertise of technologists up and down the country, including in Scotland—including, in my own constituency of Glasgow South West, a company called Cohesion Medical. His Government in Scotland, who have been in government for over 20 years, refused that offer. That is why my patients and constituents in Scotland are unable to access simple digital services. It is why my patients and my constituents under NHS Scotland are 30 times more likely to wait over two years for treatment. It is why my patients and my constituents in Scotland are unable to access optimal stroke therapy and lung cancer screening.

The NHS federated data platform in England connects health information held in different systems, helping to manage activity to improve productivity and outcomes. By connecting critical data streams, it can accelerate diagnosis pathways, streamline discharge processes and ensure faster, more co-ordinated care that reduces waiting times for all patients.

I will briefly describe a couple of examples. North Tees and Hartlepool NHS foundation trust uses an FDP product called OPTICA to map the patient’s journey from being admitted to going home. It used to be done with spreadsheets, which were not always updated. Because of that, discharges were delayed, medicines were not sorted on time—in some cases time-critical medicines, causing real patient harm—and patients were therefore impacted. OPTICA lets the trust see all that information in one place in real time. It has reduced the number of long stays by a third, and despite a 7% increase in admissions over that time, we are improving services overall.

--- Later in debate ---

[Dr Ahmed]

At the Mersey and West Lancashire teaching hospitals NHS trust, they are using the FDP to better manage the lists for planned surgery. That allows surgeons like me to operate on more people each day, and it is cutting waiting lists. This has been achieved through better use of data. It is a timely reminder that in England we are improving productivity in the national health service, getting more operations done per list and getting closer to pre-covid levels of activity. The same cannot be said for Scotland under the SNP Government.

[Seamus Logan]

Rather than giving so much of his speech to cheap political points about Scotland, can the Minister answer the question that was put to him several times by several Members: are the Government considering a review of the break clause next year?

[Dr Ahmed]

If the hon. Gentleman had read the details of any contract that the Government have negotiated, whether it is this one or the previous one, he would know that the break clause is there for a reason. Of course we evaluate value for money at those times. He used the word “cheap”, but let me tell him something: it is not cheap to have to wait over two years for NHS treatment in Scotland, which is 30 times more likely to happen than in England. That is why on 7 May the NHS in Scotland can get an upgrade with Anas Sarwar as First Minister and Jackie Baillie as Health Secretary.

The FDP is helping people get the care they need more quickly and more efficiently. As a programme, it is a success. The FDP has exceeded every single target since its go-live date in March 2024, and 137 NHS trusts are actively utilising the platform and have reported benefits. The programme is significantly exceeding its benefits forecast, with external independent experts validating these results.

NHS England publishes data on how the FDP has benefited patients and the NHS. The data collected up to the end of March will be published in May. I can share the figures with Members now. Since the go-live date in March 2024, more than 100,000 additional patients have been supported to undergo procedures in theatres, partly due to increasing theatre utilisation. Nearly 94,000 people have been supported on their cancer journey, with 7% seeing a reduction in the time taken to diagnose their cancer. There has also been a 14% decrease in delays to discharging patients staying in hospital for more than seven days, freeing up hospital beds for those who need them most.

The last Government awarded the Palantir contract on the basis of a successful bid that was deemed to be significantly better, and by a significant order of magnitude, than those of its competitors. It was judged the most economically advantageous and likely to deliver the best-quality outcome for patients. The contract was awarded with an overall value of up to £330 million over a maximum of the seven-year term. So far, £210 million has been invested, as we scale up. The benefits of the FDP are exceeding those we forecast, as I have already outlined, but—